Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder, vegetative disorders — asthenic syndrome). In the context of prevention and treatment of these symptoms, such nutraceutical products as enriched food...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2019-09-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/397 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823860163113648128 |
---|---|
author | M. V. Mayevskaya M. A. Morozova A. G. Beniashvili V. D. Lunkov V. T. Ivashkin |
author_facet | M. V. Mayevskaya M. A. Morozova A. G. Beniashvili V. D. Lunkov V. T. Ivashkin |
author_sort | M. V. Mayevskaya |
collection | DOAJ |
description | Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder, vegetative disorders — asthenic syndrome). In the context of prevention and treatment of these symptoms, such nutraceutical products as enriched foods in the form of tablets, sachets, etc, have been increasingly attracting research attention.Aim. To study the efficacy of the “Hepato Smart” nutraceutical product for the treatment of asthenic syndrome in outpatients suffering from chronic diffuse liver diseases with compensated function and functional disorders of the gallbladder over the period after exacerbation.Materials and methods. The study included 50 patients, with 41 of them having completed the program. The nutraceutical product (curcumin, piperine, tanshinone IIA, choline; standardized for curcumin and choline) was assigned 1 pill 3 times a day with meals for 4 weeks. To objectify common symptoms, we used a D-FIS questionnaire (Daily Fatigue Impact Scale), a 4DSQ Four-Dimensional Symptom Questionnaire for assessing distress, depression, anxiety and somatization, and a SF-36 questionnaire for assessing the quality of life.Results. Following 4 weeks of the “Hepato Smart” course, a statistically significant decrease in fatigue was noted by D-FIS scores (p = 0.003), as well as a decrease in the level of distress, depression, anxiety and somatization by 4DSQ scores (p = 0.005; p = 0.006; p = 0.003; p = 0.003, respectively). The quality of patients’ life according to the SF36 questionnaire also improved due to both physical and psychological components (p = 0.003). 16 patients continued taking the preparation for another 8 weeks to maintain the achieved result. As an additional effect, the disappearance of pain in the right hypochondrium was noted in those cases when patients presented this complaint at the time of inclusion in the observation program. The safety profile was good, 1/3 of the patients noted the appearance of heartburn, which was eliminated when taking the product with food.Conclusion. The “Hepato Smart” nutraceutical product improves the general condition of patients with chronic diffuse liver diseases and functional disorders of the gallbladder due to a significant reduction in fatigue and anxiety. It also improves the quality of patients’ life due to the physical and mental components of health. |
format | Article |
id | doaj-art-ddeb3729ddd44cd29588a0e3b2ffbb2a |
institution | Kabale University |
issn | 1382-4376 2658-6673 |
language | Russian |
publishDate | 2019-09-01 |
publisher | Gastro LLC |
record_format | Article |
series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
spelling | doaj-art-ddeb3729ddd44cd29588a0e3b2ffbb2a2025-02-10T16:14:35ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732019-09-01294505910.22416/1382-4376-2019-29-4-50-59319Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver DiseasesM. V. Mayevskaya0M. A. Morozova1A. G. Beniashvili2V. D. Lunkov3V. T. Ivashkin4I.M. Sechenov First Moscow State Medical University (Sechenov University)Mental Health Research CentreMental Health Research CentreI.M. Sechenov First Moscow State Medical University (Sechenov University)I.M. Sechenov First Moscow State Medical University (Sechenov University)Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder, vegetative disorders — asthenic syndrome). In the context of prevention and treatment of these symptoms, such nutraceutical products as enriched foods in the form of tablets, sachets, etc, have been increasingly attracting research attention.Aim. To study the efficacy of the “Hepato Smart” nutraceutical product for the treatment of asthenic syndrome in outpatients suffering from chronic diffuse liver diseases with compensated function and functional disorders of the gallbladder over the period after exacerbation.Materials and methods. The study included 50 patients, with 41 of them having completed the program. The nutraceutical product (curcumin, piperine, tanshinone IIA, choline; standardized for curcumin and choline) was assigned 1 pill 3 times a day with meals for 4 weeks. To objectify common symptoms, we used a D-FIS questionnaire (Daily Fatigue Impact Scale), a 4DSQ Four-Dimensional Symptom Questionnaire for assessing distress, depression, anxiety and somatization, and a SF-36 questionnaire for assessing the quality of life.Results. Following 4 weeks of the “Hepato Smart” course, a statistically significant decrease in fatigue was noted by D-FIS scores (p = 0.003), as well as a decrease in the level of distress, depression, anxiety and somatization by 4DSQ scores (p = 0.005; p = 0.006; p = 0.003; p = 0.003, respectively). The quality of patients’ life according to the SF36 questionnaire also improved due to both physical and psychological components (p = 0.003). 16 patients continued taking the preparation for another 8 weeks to maintain the achieved result. As an additional effect, the disappearance of pain in the right hypochondrium was noted in those cases when patients presented this complaint at the time of inclusion in the observation program. The safety profile was good, 1/3 of the patients noted the appearance of heartburn, which was eliminated when taking the product with food.Conclusion. The “Hepato Smart” nutraceutical product improves the general condition of patients with chronic diffuse liver diseases and functional disorders of the gallbladder due to a significant reduction in fatigue and anxiety. It also improves the quality of patients’ life due to the physical and mental components of health.https://www.gastro-j.ru/jour/article/view/397chronic diffuse liver diseasesasthenic syndromequality of lifenutraceutical product |
spellingShingle | M. V. Mayevskaya M. A. Morozova A. G. Beniashvili V. D. Lunkov V. T. Ivashkin Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases Российский журнал гастроэнтерологии, гепатологии, колопроктологии chronic diffuse liver diseases asthenic syndrome quality of life nutraceutical product |
title | Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases |
title_full | Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases |
title_fullStr | Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases |
title_full_unstemmed | Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases |
title_short | Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases |
title_sort | efficacy of physiologically active nutrients in the treatment of asthenic disorders in patients with chronic diffuse liver diseases |
topic | chronic diffuse liver diseases asthenic syndrome quality of life nutraceutical product |
url | https://www.gastro-j.ru/jour/article/view/397 |
work_keys_str_mv | AT mvmayevskaya efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases AT mamorozova efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases AT agbeniashvili efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases AT vdlunkov efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases AT vtivashkin efficacyofphysiologicallyactivenutrientsinthetreatmentofasthenicdisordersinpatientswithchronicdiffuseliverdiseases |